A 58-year-old woman was admitted with a non-ST-segment elevation myocardial infarction. (a) Angiography showed a long filling defect at the posterior descending coronary artery, with a double-lumen morphology, consistent with a spontaneous coronary artery dissection (arrows). A conservative approach was initially selected with a good clinical outcome. (b) A control angiogram 12 months after the initial episode confirmed complete resolution of the previous image, with no residual lesion at the posterior descending coronary artery.
Spontaneous coronary artery dissection (SCAD) remains an infrequent, elusive, and challenging clinical entity of unknown etiology eight decades after its initial description. Our understanding of the pathophysiology of SCAD, initially limited to information from early pathological studies, case reports, and very short series, has been enriched recently by relatively large contemporary series of patients studied prospectively. The typical presentation involves a young woman without coronary risk factors suffering an acute coronary syndrome but, actually, most patients are middleaged and have coronary risk factors. A high number of conditions have been related to SCAD, but fibromuscular dysplasia has shown a major intriguing association with potential pathophysiological implications. SCAD may present (a) with an intimal tear and the classic angiographic 'flap' leading to the appearance of two lumens (true and false), or (b) without an intimal rupture, as an intramural hematoma. An increased clinical awareness together with new diagnostic tools have led to a major surge in the diagnosis of SCAD. High-resolution intracoronary techniques provide unique diagnostic insights into the underlying pathophysiology and facilitate identification of the disease in patients misdiagnosed previously. After the initial acute ischemic insult, most patients stabilize and have a benign clinical course and eventually experience spontaneous healing of the vessel wall during follow-up. However, recurrences may still occur in up to 10-20% of cases. Accordingly, a conservative medical management (watchful waiting strategy) has been recommended as the initial approach. Revascularization remains particularly challenging and may be associated with suboptimal results, acute complications, and poor long-term outcome. Nevertheless, in patients with ongoing or refractory ischemia and adequate anatomy, revascularization should be attempted. Some novel and attractive coronary interventions have been proposed in this uniquely challenging anatomic scenario. This review aims to present a comprehensive and contemporary update on this elusive and intriguing clinical entity. Coron Artery Dis 27:696-706 Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
Introduction
Spontaneous coronary artery dissection (SCAD) is an infrequent cause of acute coronary syndrome (ACS) typically affecting young women without coronary risk factors. Our understanding of the epidemiology, etiology, pathophysiology, clinical presentation, diagnosis, management, and prognosis of patients with SCAD has been enriched by recent studies [1] [2] [3] [4] [5] [6] . An increased clinical awareness of the condition, the widespread use of early coronary angiography in patients presenting with ACS, the advent of novel diagnostic tools, and recent data from large contemporary series of patients explain the surge in the identification of this elusive clinical entity [1] [2] [3] [4] [5] [6] . SCAD represents a major cause of myocardial infarction (MI) in young women [4] . Most patients, however, are middle-aged and have coronary risk factors. Concomitant coronary artery disease may also be detected [1] [2] [3] [4] [5] [6] . A large number of associated conditions have been classically related to SCAD [1] [2] [3] [4] [5] [6] . Although the peripartum status is nowadays considered a rare predisposing condition, it still provides a unique diagnostic clue. Recently, fibromuscular dysplasia (FMD) of medium-sized extracardiac arteries has emerged as a highly prevalent associated condition with potential pathophysiological implications [1] [2] [3] [4] [5] [6] . Therefore, a systematic screening for FMD should always be performed. The extracoronary manifestations should be diagnosed, followed, and eventually treated as required. In addition, the use of intracoronary imaging, optical coherence tomography (OCT), and intravascular ultrasound (IVUS), in particular, provides novel diagnostic insights with an unprecedented axial resolution, enabling an accurate and comprehensive anatomic diagnosis of the underlying pathophysiological substrate [1] [2] [3] [4] [5] [6] . Noninvasive imaging may also be of value in selected cases, particularly with follow-up purposes. Finally, our knowledge of adequate management still remains empirical. However, accumulating evidence suggests the benefit of an initially conservative medical management (watchful waiting strategy), supporting the adoption of this strategy in a large majority of patients [1] [2] [3] [4] [5] [6] . Clinical stabilization usually ensues after the acute ischemic insult, enabling the implementation of a conservative approach. The subsequent clinical course is usually benign with a favorable long-term clinical outcome under medical management. Recurrent episodes of SCAD may occur, but are rare. Importantly, spontaneous healing on the disrupted coronary vessel wall has been observed in most of these patients at follow-up, further reinforcing the value of an initial conservative medical management. Both surgical and percutaneous revascularization are technically challenging in these patients with disrupted and friable coronary vessels. Success cannot be ensured, procedural complications remain frequent, and the longterm clinical outcome is suboptimal [1] [2] [3] [4] [5] [6] . However, in patients with adequate anatomy and ongoing or refractory ischemia, revascularization should be indicated. Surgery should be considered for patients with extensive severe disease, particularly if affecting the left main stem or involving multiple large coronary vessels. In the remaining cases, percutaneous coronary interventions (PCI) represent the treatment of choice. Coronary stents constitute the default strategy, but our armamentarium in this scenario has been reinforced recently with novel and attractive procedures including second-generation drugeluting stents, bioresorbable vascular scaffolds, and devices able to produce vessel fenestration [1, 5] . This review presents a comprehensive update on the diagnosis and management of this challenging disease.
Epidemiology
Preliminary postmortem reports were scarce and mainly based on autopsy findings after episodes of sudden cardiac death, suggesting a dismal prognosis [7] [8] [9] . Interestingly, an intimal tear was rarely detected in early pathological reports. In 1931 Pretty [7] published the first case of SCAD, a 42-year-old woman who died suddenly after severe retching and vomiting. In 1969 Forker et al. [9] reported the first angiographic diagnosis in a patient who required coronary surgery. Since then, a myriad of case reports and several small and retrospective studies have been published [10] [11] [12] [13] [14] [15] [16] [17] [18] . However, in the last 5 years, relatively large series of patients with SCAD have been published [19] [20] [21] [22] [23] [24] [25] . This explains why until very recently our knowledge of this unique clinical entity has been rather limited. Contemporary series have advanced our understanding of the natural history of the disease. Altogether, more than 1200 patients with SCAD have been reported in the literature [19] [20] [21] [22] [23] [24] [25] .
SCAD remains an infrequent clinical entity, with an estimated prevalence ranging from 0.1 to 1.1% in most angiographic studies [1] [2] [3] [4] [5] [6] . Tweet et al. [21] from the Mayo Clinic reported on 87 patients with the classical angiographic pattern of SCAD, yielding an estimated annual incidence of the condition of 0.26/100 000 persons ( Fig. 1 ). However, it is clear that the incidence of SCAD has been largely underestimated until very recently. The reasons for this include presentation as sudden cardiac death, underuse of coronary angiography in young women, and underdiagnosis by conventional angiography [1] [2] [3] [4] [5] [6] . Tomographic techniques have highlighted the inherent limitations of classical angiography, which only depicts the lumen silhouette, in detecting SCAD. Accordingly, initially, only cases with the classical angiographic intimal flap and a double angiographic lumen could be diagnosed. Early studies indicated a very high prevalence of women, although recent series that also included patients with associated atherosclerotic coronary artery disease have found a significant proportion of male patients [10] [11] [12] [13] [14] [15] [16] [17] [18] . These patients tend to be older and more frequently have coronary risk factors. The term 'primary' or 'isolated' SCAD is reserved for patients with otherwise normal coronary arteries. Typical presentation occurs in young women, but recent series suggest that most patients actually present in the fifth-sixth decades of life [10] [11] [12] [13] [14] [15] [16] [17] [18] . However, the diagnosis of SCAD should always be kept in mind in young patients, particularly women, presenting with ACS. Most patients present with an STsegment elevation or non-ST-segment elevation acute MI [10] [11] [12] [13] [14] [15] [16] [17] [18] . In our series of 45 consecutive patients with SCAD, 27 (60%) had 'isolated' SCAD and 18 had SCAD associated with coronary artery disease [19] . The mean age of the patients was 53 years, 58% of patients were women, and most of them (76%) presented with an acute MI [19] . Some investigators suggest that SCAD constitutes the underlying substrate in one out of four women younger than 50 years old presenting with ACS [26] . The left anterior descending coronary artery is the vessel that is more frequently involved and up to 10% of cases have multivessel involvement [10] [11] [12] [13] [14] [15] [16] [17] [18] .
Pathophysiology
Although the pathogenesis of SCAD still remains unsettled, two main pathological subsets are considered according to the presence or absence or an intimal tear [1] [2] [3] [4] [5] [6] . It is accepted that a primary intimal rupture generates an entry door precipitating bleeding into the coronary wall with the development of a false lumen that communicates with the true lumen ('inside-out' mechanism). Pressure-driven expansion of the false lumen leads to axial propagation of the dissection and further compression of the true lumen. Importantly, early pathological studies showed that in most patients, the dissection plane is not separating the intima from the media, but rather the intima and the inner two-thirds of the media from the residual outer third of media that remains closely joined to the adventitia [1] [2] [3] [4] [5] [6] . Alternatively, in patients without an intimal tear, a primary disruption of the 'vasa vasorum' leading to intramedial hemorrhage is considered to be the underlying etiology ('outside-in' mechanism). In this setting, there is no communication between the true and the false lumen, and actually the latter is an intramural hematoma [1] [2] [3] [4] [5] [6] . Myocardial ischemia results from compression of the true lumen. Most patients present with an ACS frequently with ST-segment elevation MI. Other patients may present with stable angina, syncope, ventricular arrhythmias, cardiogenic shock, or even sudden cardiac death [10] [11] [12] [13] [14] [15] [16] [17] [18] .
In patients with associated atherosclerotic coronary artery disease, a rupture of a fibroatheroma may eventually lead to the formation of two lumens. In rare instances, the extension of this process is long enough to generate a double-lumen morphology mimicking that observed in SCAD. However, in patients with atherosclerotic disease, the underlying pathophysiology diverges from that observed in the classical patients with primary or isolated SCAD. Similarly, by definition, iatrogenic dissections and those secondary to trauma are not considered in the diagnosis of SCAD [27] .
The reasons behind this 'vulnerable' coronary vessel wall remain unknown, but may be multifaceted [1] [2] [3] [4] [5] [6] . Classical studies suggested that pregnancy and the puerperium are high-risk periods in young women. The related hormonal, hemodynamic, and prothrombotic changes of this special period might predispose to SCAD [1] [2] [3] [4] [5] [6] . It has been suggested that estrogens may modify arterial wall architecture, affecting the elastic fibers, mucopolysaccharide composition, and collagen synthesis, eventually causing a weakened wall [1] [2] [3] [4] [5] [6] . Some patients with SCAD show accumulation of eosinophilic infiltrates on the adventitia and it has been suggested that their cytotoxic activity could promote the development of pathological changes and even cystic medial necrosis [2, 28] . Conversely, these eosinophilic infiltrates might only be a bystander or represent a secondary inflammatory reaction [2] . However, in patients with connective tissue disorders, medial degeneration may explain the arterial weakness [1] [2] [3] [4] [5] [6] . Finally, recent reports suggest a strong association between SCAD and FMD [29] [30] [31] [32] [33] [34] . FMD in middle-sized arteries produces a vast array of degenerative changes that may lead to dissection of the arterial vessel wall.
Triggers and associated conditions
The importance of triggers and exacerbating factors has been emphasized by many investigators. Local shear stress might play an important pathophysiologic role. Vigorous aerobic physical exercise, heavy isometric exercise, blunt chest trauma, Valsalva maneuver, and repeat coughing or squeezing have been associated with SCAD [1-6,10-18]. In addition, SCAD has been reported to be elicited by mental stress, drug abuse (mainly cocaine), vasoconstrictor substances (for intercurrent migraine), hormonal therapy [35] , and coronary artery spasm. In the series of Saw et al. [22] , emotional stress was present in 26% of cases and any precipitating stress could be documented in 56% of patients [35] . Women are more likely to report precipitant emotional stress and less frequently exercise-related stress than men [36] . Catecholamine surges increase aortic pressure and myocardial contractility, and facilitate vasospasm [1] [2] [3] [4] [5] [6] .
SCAD has been associated with multiple clinical situations that may provide a potential underlying substrate including pregnancy, peripartum, and perimenopausal periods, and also with the use of oral contraceptives. In a series from Canada, 27% of patients had a history of migraines and 29% had a history of depression [22] . In addition, many systemic connective tissue disorders (Marfan, Ehlers-Danlos, Loeys-Dietz syndromes, and systemic lupus erythematosus) [1] [2] [3] [4] [5] [6] , inflammatory, or immunologic conditions (rheumatoid arthritis, polyarteritis nodosa, Crohn's disease, sarcoidosis, and polycystic kidney disease) have all been classically associated with this clinical entity. Actually, a myriad of conditions, with their corresponding pathophysiological hypotheses, have been reported to be associated with this condition [1] [2] [3] [4] [5] [6] . However, when the presence of inmmunologic and inflammatory markers has been systematically assessed in patients presenting with SCAD, no significant abnormalities were found in the vast majority of cases [19] .
FMD is another elusive condition of unknown etiology linked recently to SCAD [29] [30] [31] [32] [33] [34] . FMD is a noninflammatory, nonatherosclerotic, vascular disease of medium-large muscular arteries and also affects young women. The disease manifests as arterial stenosis, dissection, thrombosis, or aneurysms [29] [30] [31] [32] [33] [34] . Multiple large arterial beds may be involved, but the renal and carotid arteries are most often affected. Histologically, FMD is highly heterogeneous [29] [30] [31] [32] [33] [34] . Medial fibroplasia accounts for 90% of cases. The characteristic angiographic pattern consists of alternating stenotic segments with poststenotic dilation, resulting in the 'string-ofbeads' appearance that constitutes the hallmark of this disease [29] [30] [31] [32] [33] [34] . Other FMD subtypes include intimal fibroplasia (presenting as focal or tubular lesions) and perimedial fibroplasia (with small beads) [28] [29] [30] [31] [32] . FMD frequently associates with arterial tortuosity. As FMD is usually clinically silent, the disease is frequently underdiagnosed or incidentally discovered [30] . There has been little progress in our understanding of its pathogenesis and prognosis since its first description back in 1938 [29, 30] . Recently, Olin et al. [30] reported a series of 447 patients enrolled in a national-level USA FMD registry. Of these, 19% had had a transient ischemic attack or stroke, 20% had experienced arterial dissection, and 17% had aneurysms. Clinical manifestations included hypertension, headache, tinnitus, and dizziness [30] . However, only 1.9% of patients had previous MI. Moreover, although 20% of patients presented with arterial dissections, these affected the coronary arteries in only 3.4% of cases. Although FMD has been reported to be a rare cause of MI and sudden death, the involvement of the coronary arteries per se has only been reported occasionally and, in general, very poorly documented [32] [33] [34] . Further studies are required to assess whether the identification of the early stages of coronary FMD may determine patients at risk for subsequent SCAD.
The group from Vancouver [37] [38] [39] first described the association between FMD and SCAD. Initially, they reported seven perimenopausal women presenting with a MI showing diffuse lesions in mid-distal coronary segments and coincidental renal FMD [37] .
Angiographically, an abrupt transition to long lesions in distal coronary segments was visualized in patients with otherwise completely normal coronary arteries. Subsequently, these investigators were able to confirm, using IVUS or OCT, that these unusual angiographic appearances actually corresponded to intramural hematomas [38, 39] . Subsequently, Saw et al. [22] from the same group performed a systematic screening for FMD in 50 patients with SCAD. Interestingly, FMD was documented in 86% of screened patients, most of them showing the involvement of several noncoronary vascular territories (renal, iliac, and cerebrovascular). In addition, cerebral or carotid aneurysms were detected in 14% of patients. Patients with FMD had more severe coronary tortuosity. These investigators suggested that this uniquely high prevalence of the association between these two rare diseases strongly suggested a potential causative link [37] [38] [39] . A confirmatory report from the Mayo Clinic [21] showed that 50% of patients with SCAD undergoing iliofemoral angiography had incidental external iliac FMD. Other recent reports from the same group [40, 41] using noninvasive computed tomography-angiography reported the presence of extracoronary vascular abnormalities (including FMD, aneurysms, dissection, and major aortic tortuosity) in 2/3 of patients presenting with SCAD. In this study, the presence of FMD or other extracoronary vascular abnormalities was not associated with recurrences or with an adverse clinical outcome [40, 41] . Obviously, the prevalence of these abnormalities is lower in series with a limited imaging screening protocol than in studies using a dedicated comprehensive and systematic diagnostic protocol [41] . Considering the high prevalence of FMD in patients with SCAD, this association should be investigated systematically (Fig. 2) . Further studies are warranted to ascertain whether a coincidental association, or rather causation, exists between these unique clinical entities [37] [38] [39] [40] [41] [42] [43] [44] .
Diagnosis
A precise early diagnosis is important to implement the appropriate management strategies that significantly differ from those used in patients with ACS secondary to coronary atherosclerosis [1] [2] [3] [4] [5] [6] .
Conventional coronary angiography
Coronary angiography represents the main diagnostic tool in SCAD [10] [11] [12] [13] [14] [15] [16] [17] [18] . The classical appearance is a longitudinal filling defect generating a double coronary lumen (Fig. 1 ). This radiolucent intimal 'flap' constitutes the angiographic hallmark of SCAD [10] [11] [12] [13] [14] [15] [16] [17] [18] . Dye staining may also suggest the presence of slow flow in the false lumen. In this scenario, a meticulous analysis of a highquality angiogram by experienced observers is of utmost importance. Intracoronary nitroglycerin administration is mandatory to ensure complete vasodilation, to optimize angiographic images, and to rule out the presence of coronary artery spasm. Multiple views should be performed to ascertain indirect signs of lumen compromise and eventually to identify a hidden angiographic flap.
The angiographic procedure should also ensure adequate visualization of the distal vasculature. The NHLBI classification was developed to assess 'iatrogenic' dissections, but this diagnostic scheme is also frequently used to define the angiographic patterns of patients with SCAD. Nevertheless, it is important to keep in mind that angiography may overlook the diagnosis in patients presenting with an intramural hematoma that may mimic focal or diffuse atherosclerotic lesions [5] . A focal or a diffuse lesion in a young patient with a completely smooth appearance of the remaining coronary vessels should raise the clinical suspicion of an intramural hematoma [5] . In this respect, Saw [45] proposed a simple angiographic classification for SCAD. Type 1 represents the classical angiographic flap with a double lumen. Alternatively, intramural hematomas may present as either type 2 (diffuse smooth stenosis) or type 3 (focal stenosis mimicking atherosclerosis) angiographic patterns. In our experience, intracoronary imaging is required to confirm the diagnosis in most patients with type 2 and type 3 angiographic patterns. Importantly, the group from the Mayo Clinic [24] recently showed that patients with SCAD (n = 246) had more tortuous coronary arteries than a well-matched (age and sex) control group (n = 300). These 'curly' coronary arteries, including those reaching an extreme 'corkscrew' morphology, provide a valuable diagnostic clue when they encompass an isolated confined narrowing. Importantly, in the series from the Mayo Clinic, severe coronary tortuosity was related, on the one hand, to hypertension and concomitant extracoronary vasculopathy (including FMD) and, on the other, to a higher recurrence risk during clinical follow-up [24] . Similarly, in the Canadian series, coronary tortuosity has been reported to occur in patients with suspected coronary FMD. In our experience, a tortuous but healthy-looking coronary vessel, showing a segment with confined diffuse lumen narrowing, particularly when this results in a 'straightening' of the lumen or in a 'brokenline' lumen morphology, should always raise the clinical suspicion of an underlying intramural hematoma [1, 5] .
Intracoronary imaging
Until very recently, the angiographic narrowing caused by an intramural hematoma impinging into the lumen was misdiagnosed systematically as atherosclerotic coronary artery disease [1] [2] [3] [4] [5] [6] . IVUS and, more recently, OCT provide high-resolution, tomographic insights into the diagnosis of this entity [1] (Figs 3 and 4 ). Ultimately, SCAD remains a disease of the vessel wall that can only be characterized adequately using high-resolution tomographic techniques [1] .
IVUS (axial resolution 150 μm) provides a clear picture of the vessel wall and can differentiate the normal vessel wall or atherosclerotic plaques from SCAD. IVUS easily depicts the true and the false lumens and can visualize the thrombosis of the false lumen [46] [47] [48] [49] . Importantly, ultrasound deeply penetrates into the vessel wall, providing a full picture of the longitudinal and circumferential extension of the false lumen ( Fig. 4) . Even in the presence of large hematomas, the outer border of the vessel wall (external elastic lamina) is well recognized. IVUS penetrates the thrombus and does not require blood clearance to obtain satisfactory pictures. However, because of inadequate near-field resolution and ringdown artifacts, sometimes, an intimal flap closely 
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Extracoronary vascular abnormalities in a patient with spontaneous coronary artery dissection. Both extracranial right (a) and left (b) internal carotid arteries showed the characteristic 'string-of-beads' pattern (arrows), suggesting underlying fibromuscular dysplasia. The study also showed the presence of bilateral aneurysms in the intracranial portion of both internal carotid arteries (arrowheads). surrounding the catheter is poorly defined. In addition, in most cases, the location of the intimal rupture cannot be identified [46] [47] [48] [49] .
More recently, OCT with a superbnear histologicalaxial resolution (15 μm) has been used in the diagnosis of SCAD [50] [51] [52] [53] . OCT provides a unique visualization of the intimomedial membrane along the entire diseased segment (Fig. 5) . In fact, the thickness of this membrane, which usually encompasses the intima and the two inner thirds of the media, can be analyzed and measured accurately. In a previous prospective study, we used OCT in 17 consecutive patients with a clinical or an angiographic suspicion of SCAD [53] . In our series, OCT was very useful to exclude the presence of the disease in six patients with a suspicious lumen narrowing. In the remaining 11 patients, OCT was instrumental in confirming the presence of SCAD, providing striking images of the underlying substrate [53] . Importantly, only three patients in this series had the classical angiographic intimal flap. OCT easily visualized the affected coronary wall along the entire vessel. The complete length (32 12 mm) of the diseased segment (double lumen or intramural hematoma) could be easily disclosed. In most patients, the membrane was relatively thick (mean 350 μm) and actually consisted of intima plus the inner media. The two lumens (true and false) could be identified easily. OCT provided very sharp 'crispy' images of the intimal-lumen interface and enabled very precise measurements of the true lumen (area and diameters). The take-off and involvement of related side branches could be visualized easily. Finally, associated thrombus was detected in most cases, although in some patients, the shadowing caused by a red thrombus obscured the vessel. Importantly, because of its unique resolution, this technique could identify the intimal tear in seven of the 11 patients [53] . In summary, we believe that the anatomic information unraveled by OCT may help to inform the clinical decision-making process (Figs 3 and 5 ).
In our experience, OCT is also of major value in the cohort of SCAD patients requiring revascularization [48, 53] . Before stenting, it is critical to confirm that the guidewire is located in the true lumen. Besides, OCT may ensure that the 'entry door' has been sealed by the stent. In addition, the length of the stent may be well planed according to the longitudinal extent of the disease and the compromise of the true lumen. Propagation of intramural hematoma is a feared complication of interventions that may be identified with OCT. Extensive hematomas may lead to stent undersizing, with the associated risk of late malapposition on hematoma resorption. Residual abluminal intramural hematoma and residual distal dissections are detected frequently after stenting but, in most cases, require no treatment [50] [51] [52] [53] [54] . Importantly, during follow-up, OCT can confirm the spontaneous healing of the dissection and in most patients a 'restitutio ad integrum' of the vessel wall can be shown [53] . Limitations of OCT include the requirement of flushing with contrast media of the coronary lumen, shadowing or attenuation of dorsal structures by associated thrombus or hematoma, and incomplete visualization of large intramural hematomas as a result of the limited field of view [49] . Although both intracoronary techniques provide excellent images, they should be used with caution by experienced operators to prevent further vessel injury [53] . 
Noninvasive imaging
Despite its attractiveness, the scarce information currently available on the diagnostic value of multislice computed tomography (MSCT) in patients with SCAD is indeed surprising [55] [56] [57] . This noninvasive technique can detect a double coronary lumen or a low-density signal surrounding the lumen in cases with intramural hematoma [55] [56] [57] . However, the spatial resolution of MSCT currently limits its diagnostic value to patients with proximal involvement of large vessels. Assessment of the involvement of distal coronary vessels is very challenging, but critical in SCAD as this entity frequently affects the distal or the branch vasculature. MSCT appears to be especially suitable for follow-up purposes, providing a dynamic picture of the natural history of SCAD [53] [54] [55] [56] [57] . Furthermore, MSCT eliminates the potential likelihood of vessel wall injury during invasive procedures. Roura et al. [57] reported the largest series of patients with SCAD studied by MSCT. In 83% of cases, complete resolution of the SCAD image was shown. Importantly, patients showing vessel wall healing at 3-6 months of MSCT follow-up had an excellent prognosis. However, the value of MRI in this setting remains poorly established. Although this technique has a relatively low resolution, hyperintensity areas can be shown during the acute event and subsequently its resolution can be visualized at follow-up [58] .
Medical management
The management of patients with SCAD still remains empirical and highly controversial [1] [2] [3] [4] [5] [6] . This is because of the rarity of the disease, explaining the absence of comparative studies assessing the relative efficacy of different therapeutic strategies [1] [2] [3] [4] [5] [6] [19] [20] [21] [22] . Most patients are managed clinically according to general recommendations for ACS patients, but using a conservative antithrombotic/antiplatelet strategy. Potent antiplatelet drugs and anticoagulants are a double-edged sword as they may prevent progressive thrombus formation and vessel occlusion but, in contrast, by preventing vessel healing and false lumen thrombosis, they may also facilitate progression and extension of the disease. Classical wisdom indicates that the use of fibrinolysis and IIb/IIIa platelet inhibitors is contraindicated in these patients as they might further increase intramural bleeding [1] [2] [3] [4] [5] [6] . Unfortunately, some patients with SCAD presenting with ST-segment elevation MI are treated with fibrinolysis before a definitive diagnosis and some reports suggest deleterious effects. In some series [59] , SCAD patients who received thrombolysis experienced clinical deterioration, leading to rescue interventions. Many investigators suggest the combined use of aspirin and clopidogrel, but an individualized management according to the perceived risk of thrombosis versus disease extension appears to be reasonable considering the lack of solid evidence. Patients with an intramural hematoma are probably less likely to benefit from a dual antiplatelet regimen compared with those with an intimal rupture, but this assumption remains completely speculative. Data on the potential value of novel antiplatelet agents (prasugrel or ticagrelor) are not available, but these potent agents are usually not indicated in this scenario [1] [2] [3] [4] [5] [6] .
β-Blockers remain the mainstay of medical therapy [1] [2] [3] [4] [5] [6] as they reduce oxygen consumption and local shear stress. Their potential value in preventing recurrences, although highly attractive (able to blunt catecholamine surges), remains speculative. Nitroglycerin and calciumchannel blockers may be used at presentation and maintained in patients with diffusely vasospastic arteries, in those with associated coronary artery spasm, or just to counterbalance the effects of β-blockers on the arterial tone. Statins should be used in patients with abnormal lipid levels, although an observational study suggested that these agents might increase the risk of recurrences [21] . This observation, however, was derived from a retrospective analysis that may be confounded by other factors. Angiotensin-converting enzyme inhibitors should be used in patients with left ventricular dysfunction secondary to MI. The lack of prospective controlled data to guide pharmacotherapy in SCAD is a major limitation. Therefore, in the absence of evidence-based recommendations, pragmatic clinical judgment is of paramount importance in the clinical management of these patients.
Revascularization
In patients with SCAD, revascularization is very challenging because of the presence of a disrupted and highly friable vessel wall. The fragility of the vessel wall and the presence of a false lumen or an intramural hematoma hamper the results of both surgical and percutaneous techniques [1] [2] [3] [4] [5] [6] . Accordingly, a 'watchful waiting' strategy has been proposed for stabilized patients with SCAD ( Fig. 1 ). Most recent series suggest an excellent clinical outcome following a conservative medical management strategy in most patients presenting with SCAD [19] [20] [21] [22] . After initial clinical presentation as an ACS, most patients with SCAD have a favorable clinical course. A diagnostic and clinical management algorithm of revascularization is summarized in a flow diagram (Fig. 6 ).
In a previous study, we followed a prospective clinical protocol for the diagnosis and management of SCAD. A conservative medical strategy was recommended systematically as the first option and revascularization was only considered in patients with ongoing or recurrent ischemia. A high level of clinical suspicion was maintained and, in cases with equivocal angiographic findings, intracoronary imaging was recommended [19] . Of [19] .
In a Canadian series of 50 patients with SCAD, revascularization was only needed in 18% of patients during admission [22] . In this study, a conservative medical approach was also followed in most patients, with excellent long-term clinical outcomes. In a subsequent report from this group [23] , procedural success was only achieved in 64% of patients, but only 30% maintained durable results at long-term follow-up. In the large series from the Mayo Clinic [21] , up to 2/3 of patients underwent coronary revascularization during initial hospitalization. Coronary interventions were associated with high rates of complication and emergency coronary surgery even in patients presenting with preserved coronary flow. Procedural success was only achieved in 65% of procedures and disease propagation during the interventions occurred in 16% of patients. Revascularization did not reduce the long-term risk of new revascularization or recurrent SCAD. Although this series includes interventions performed many years agowithout the currently available technologyit highlights the complexity and the risk of complications associated with revascularization in patients with SCAD [25] .
Revascularization should be considered in patients with ongoing or refractory ischemia [1] [2] [3] [4] [5] [6] (Fig. 6) guidewire in the true lumen and the risk of dissection extension, intramural hematoma axial propagation, or side-branch occlusion [19] [20] [21] [22] . Notably, catheter-induced iatrogenic dissections occur more frequently during interventions in patients with SCAD. Even if coronary stenting is indicated, a conservative stenting strategy should be followed. In relatively confined dissections or hematomas, some investigators have suggested the use of relatively long stents targeting healthy proximal and distal landing zones to prevent propagation of the disease. However, in cases of diffuse SCAD, most investigators clearly advocate for a conservative stenting approach sealing the 'entry door' and the most severe and proximal coronary segments [19, 21, 25] . Leaving the distal part of the dissection untreated has been advocated to prevent the propagation of the disease and to avoid the long-term consequences of a full metal jacket strategy [54] . Intracoronary imaging may help to visualize that the guidewire is in the true lumen and to guide the procedure by depicting the location of the intimal tear and the full longitudinal extent of the disease. In addition, coronary imaging appears to be very useful to optimize stent implantation and to assess the final results and, in particular, the characteristics of the residual abluminal intramural hematoma and the residual dissections [50, 53] .
DES appear to be superior to conventional bare-metal stents to reduce the risk of restenosis, especially when long segments need to be covered. Whether DES may delay healing of the underlying vessel wall remains speculative. Very recently, the use of cutting or scoring balloons has been advocated in selected patients to fenestrate the intimomedial membrane to decompress the false and true lumens [60] [61] [62] . Some reports show that this strategy is associated with an improvement in the appearance of the true lumen and normalization of coronary flow. Similarly, conceptually, the value of bioresorbable vascular scaffolds is very appealing in this scenario [63] [64] [65] . The rationale is to scaffold the true lumen and subsequently allow a full vessel wall restoration. However, no information exists on the relative efficacy of the currently available interventions in this unique anatomic setting (Fig. 6 ).
Finally, coronary bypass grafting should be reserved for patients with anatomy unsuitable for PCI and refractory symptoms. This includes patients with dissection of the left main and additional coronary segments and also patients with severe multivessel involvement and good distal vessels [1] [2] [3] [4] [5] [6] . Vessel frailty and the presence of two lumens may explain the difficulties enountered during the performance of the distal anastosis and also the poor fate of the grafted vessels. In the series from the Mayo Clinic, the results of coronary surgery were very disappointing [21, 25] . Initial operative results and inhospital clinical outcomes were favorable. However, at late angiographic surveillance, most arterial conduits were occluded [21, 25] .
Conclusion
SCAD is currently increasingly being recognized, but diagnosis and treatment remain challenging. Intracoronary diagnostic techniques provide novel diagnostic pathophysiological insights. FMD represents a frequent underlying condition with potential clinical implications. Although revascularization strategies are improving in this scenario, an initial conservative medical management remains the strategy of choice for most of these patients.
